L. L. Solovenchuk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
L. L. Solovenchuk has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Boris V. Sheplev
Institute of Chemical Biology and Fundamental Medicine Novosibirsk Russia
2 shared publications - Igor V. Maiborodin
Novosibirskii mediko-stomatologicheskii institut Dentmaster; Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences
2 shared publications - Sergey Fursov
Novosibirsk State Medical University, Ministry of Health of Russia
2 shared publications - Victor Gorbachev
Plekhanov Russian University of Economics
2 shared publications A. B. Нибожин
Новосибирский государственный медицинский университет Минздрава России; Новосибирский областной онкологический диспансер
1 shared publication- A. G. Lapinski
Russian Academy of Sciences
1 shared publication
Latest Publications
- Open Access
- 5 November 2026
- Published by Institute of Cytology and Genetics, SB RAS in Siberian Scientific Medical Journal
- Vol. 46 (5) , 65-72
Expression of plasma cell markers in colon cancer and lung adenocarcinoma
Certain clusters of differentiation that are markers of plasma cells (CD38 and CD138) can be expressed not only on plasma cells infiltrating the tumor and its microenvironment, but also on the tumor cells themselves and in the stroma of malignant neoplasms. The literature is divided on the expression of the proteoglycan CD138 (syndecan-1), which can be detected on the cells and structures of colon cancer and lung adenocarcinoma. Most publications claim that this proteoglycan delays tumor development, and that its loss is associated with epithelial-mesenchymal transition, decreased in the degree of cancer differentiation, and an unfavorable prognosis for patients. At the same time, there are also directly contradictory observations, testifying that patients with high levels of syndecan-1 have a poor prognosis, suppression of its expression weakens the invasive capacity of cultured tumor cells, inhibits tumor growth and metastasis. Some human cell lines and tissue samples of lung adenocarcinoma have increased expression of the characteristic plasma cell differentiation cluster CD38, which, according to the general opinion of researchers, is associated with a poor prognosis for patients. Such marked inconsistency in publications may serve as evidence that the issue of plasma cell marker expression in malignant tissues is advisable to study in more detail and more widely. Only a comprehensive approach to this problem can lead to significant results in the study of the fundamental mechanisms of adhesion and functioning of tumor cells, which may have not only theoretical but also practical significance due to the possibility of influencing the pathogenetic mechanisms of cancer progression.
- 5 November 2026
- Published by Institute of Cytology and Genetics, SB RAS in Siberian Scientific Medical Journal
- Vol. 46 (5) , 65-72
Open AccessExpression of plasma cell markers in colon cancer and lung adenocarcinoma
Certain clusters of differentiation that are markers of plasma cells (CD38 and CD138) can be expressed not only on plasma cells infiltrating the tumor and its microenvironment, but also on the tumor cells themselves and in the stroma of malignant neoplasms. The literature is divided on the expression of the proteoglycan CD138 (syndecan-1), which can be detected on the cells and structures of colon cancer and lung adenocarcinoma. Most publications claim that this proteoglycan delays tumor development, and that its loss is associated with epithelial-mesenchymal transition, decreased in the degree of cancer differentiation, and an unfavorable prognosis for patients. At the same time, there are also directly contradictory observations, testifying that patients with high levels of syndecan-1 have a poor prognosis, suppression of its expression weakens the invasive capacity of cultured tumor cells, inhibits tumor growth and metastasis. Some human cell lines and tissue samples of lung adenocarcinoma have increased expression of the characteristic plasma cell differentiation cluster CD38, which, according to the general opinion of researchers, is associated with a poor prognosis for patients. Such marked inconsistency in publications may serve as evidence that the issue of plasma cell marker expression in malignant tissues is advisable to study in more detail and more widely. Only a comprehensive approach to this problem can lead to significant results in the study of the fundamental mechanisms of adhesion and functioning of tumor cells, which may have not only theoretical but also practical significance due to the possibility of influencing the pathogenetic mechanisms of cancer progression.
- Open Access
- 17 May 2026
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 25 (2) , 165-174
Colorectal cancer: angiogenesis and matrix metalloproteinases
Aim : to summarize the available literature data on the role of matrix metalloproteinases (MMPs) in angiogenesis, as well as in the development and progression of colorectal cancer (CRC). Material and Methods . A literature search was conducted in the Medline and eliBRARY.RU databases from 1999 to the present using the keywords “angiogenesis + cancer + colon + MMP”. Results. Malignant tumors are characterized by the ability to form new vessels, invade surrounding tissues, and metastasize to distant organs, and this aggressiveness depends on the expression of proteolytic enzymes, including MMPs. in CRC, the levels of MMPs are increased in both tumor tissues and blood plasma; these enzymes are required for extracellular matrix remodelling during angiogenesis, tumor invasion and metastasis. The degree of overexpression of certain MMPs correlates with the stage of CRC, vascularization, VEGF expression and/or prognosis; however, not all researchers agree with these findings. MMPs are synthesized both by tumor cells and, more prominently, stromal cells like tumor-associated macrophages. Alterations in the function of immunocompetent and stromal cells that express and produce MMPs play a key role in both the initiation and progression of CRC. Targeting tumor-associated immunocompetent and stromal cells, their reprogramming, neutralization and/or inhibition of their trafficking may delay the growth and invasion of CRC. inhibition of MMPs may represent one of the stages of antiangiogenic therapy. in addition to suppressing angiogenesis, certain MMP inhibitors stimulate apoptosis, suppress cell proliferation, induce cell cycle arrest, and reduce the expression of antiapoptotic genes of the Bcl family. A wide range of artificial and natural compounds and methods has been proposed as MMP inhibitors. However, despite promising experimental results, clinical trials of MMP inhibitors have been largely disappointing. There is evidence that some MMPs exert antitumor effects, and their blockade may be accompanied by tumor progression. Conclusion . A wide variety of approaches to targeting MMPs, together with the certain inconsistency of available data, may indicate the persisting dissatisfaction of researchers and clinicians with the current solutions to the problem of MMP-mediated angiogenesis in tumor tissues. This also highlights the need for continued investigation into both the effects of MMPs in CRC and the methods for controlling the activity of this enzyme group.
- 17 May 2026
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 25 (2) , 165-174
Open AccessColorectal cancer: angiogenesis and matrix metalloproteinases
Aim : to summarize the available literature data on the role of matrix metalloproteinases (MMPs) in angiogenesis, as well as in the development and progression of colorectal cancer (CRC). Material and Methods . A literature search was conducted in the Medline and eliBRARY.RU databases from 1999 to the present using the keywords “angiogenesis + cancer + colon + MMP”. Results. Malignant tumors are characterized by the ability to form new vessels, invade surrounding tissues, and metastasize to distant organs, and this aggressiveness depends on the expression of proteolytic enzymes, including MMPs. in CRC, the levels of MMPs are increased in both tumor tissues and blood plasma; these enzymes are required for extracellular matrix remodelling during angiogenesis, tumor invasion and metastasis. The degree of overexpression of certain MMPs correlates with the stage of CRC, vascularization, VEGF expression and/or prognosis; however, not all researchers agree with these findings. MMPs are synthesized both by tumor cells and, more prominently, stromal cells like tumor-associated macrophages. Alterations in the function of immunocompetent and stromal cells that express and produce MMPs play a key role in both the initiation and progression of CRC. Targeting tumor-associated immunocompetent and stromal cells, their reprogramming, neutralization and/or inhibition of their trafficking may delay the growth and invasion of CRC. inhibition of MMPs may represent one of the stages of antiangiogenic therapy. in addition to suppressing angiogenesis, certain MMP inhibitors stimulate apoptosis, suppress cell proliferation, induce cell cycle arrest, and reduce the expression of antiapoptotic genes of the Bcl family. A wide range of artificial and natural compounds and methods has been proposed as MMP inhibitors. However, despite promising experimental results, clinical trials of MMP inhibitors have been largely disappointing. There is evidence that some MMPs exert antitumor effects, and their blockade may be accompanied by tumor progression. Conclusion . A wide variety of approaches to targeting MMPs, together with the certain inconsistency of available data, may indicate the persisting dissatisfaction of researchers and clinicians with the current solutions to the problem of MMP-mediated angiogenesis in tumor tissues. This also highlights the need for continued investigation into both the effects of MMPs in CRC and the methods for controlling the activity of this enzyme group.
- 1 January 2024
- Published by FSBEI HE NSMU MOH Russia in Sibirskij medicinskij vestnik
- Vol. 8 (2)
CHANGE IN THE PHENOTYPE OF BREAST CANCER AFTER TREATMENT
Breast cancer ranks first in mortality among cancer diseases in women. This figure is not decreasing, despite new data being obtained annually on the morphology of breast cancer and advances in its treatment. According to global standards, in order to prescribe effective treatment, it is necessary to know the phenotype of the tumor which is determined by the expression of a number of markers, such as estrogen and progesterone receptors (ER, PR), HER2/neu and Ki 67. According to numerous studies, it has been revealed that native, residual, recurrent and metastatic tumors may differ in phenotype, regardless of the initially established variant. In addition, changes in the immunophenotype of the tumor are also affected by the treatment performed. At the moment, enough data have been accumulated around the world confirming the possibility of changing the tumor phenotype. However, to date, there are no standards regulating the additional IHC studies after treatment, or when a recurrent/metastatic lesion is detected. Carrying out additional immunophenotyping of the tumor can help reduce the likelihood of prescribing ineffective treatment and select the most optimal therapy in each specific case.
- 1 January 2024
- Published by FSBEI HE NSMU MOH Russia in Sibirskij medicinskij vestnik
- Vol. 8 (2)
CHANGE IN THE PHENOTYPE OF BREAST CANCER AFTER TREATMENT
Breast cancer ranks first in mortality among cancer diseases in women. This figure is not decreasing, despite new data being obtained annually on the morphology of breast cancer and advances in its treatment. According to global standards, in order to prescribe effective treatment, it is necessary to know the phenotype of the tumor which is determined by the expression of a number of markers, such as estrogen and progesterone receptors (ER, PR), HER2/neu and Ki 67. According to numerous studies, it has been revealed that native, residual, recurrent and metastatic tumors may differ in phenotype, regardless of the initially established variant. In addition, changes in the immunophenotype of the tumor are also affected by the treatment performed. At the moment, enough data have been accumulated around the world confirming the possibility of changing the tumor phenotype. However, to date, there are no standards regulating the additional IHC studies after treatment, or when a recurrent/metastatic lesion is detected. Carrying out additional immunophenotyping of the tumor can help reduce the likelihood of prescribing ineffective treatment and select the most optimal therapy in each specific case.
- 1 November 2011
- Published by Pleiades Publishing Ltd in Russian Journal of Marine Biology
- Vol. 37 (6) , 489-493
Intraspecies structure of the pacific herring Clupea pallasii valenciennes, 1847 (Clupeidae: Clupeiformes) in the Sea of Japan and the southern Sea of Okhotsk inferred from the variability of mitochondrial DNA control
The differentiation of local herring populations from the Sea of Japan and the southern Sea of Okhotsk was assessed on the basis of mtDNA (mitochondrial DNA) control region variability. Three samplings of sea herring and one sampling of lake herring were studied. The genetic analysis showed a significant (P < 0.01) difference between lake and sea herring samplings and no differentiation among sea samplings (P > 0.05). AMOVA analysis revealed that only 4.11% of the variability was attributed to the interpopulation component, while variability within populations was 95.89%. It is suggested that the reason for the weak differentiation of local sea herring populations may be an intensive gene flow.
- 1 November 2011
- Published by Pleiades Publishing Ltd in Russian Journal of Marine Biology
- Vol. 37 (6) , 489-493
Intraspecies structure of the pacific herring Clupea pallasii valenciennes, 1847 (Clupeidae: Clupeiformes) in the Sea of Japan and the southern Sea of Okhotsk inferred from the variability of mitochondrial DNA control
The differentiation of local herring populations from the Sea of Japan and the southern Sea of Okhotsk was assessed on the basis of mtDNA (mitochondrial DNA) control region variability. Three samplings of sea herring and one sampling of lake herring were studied. The genetic analysis showed a significant (P < 0.01) difference between lake and sea herring samplings and no differentiation among sea samplings (P > 0.05). AMOVA analysis revealed that only 4.11% of the variability was attributed to the interpopulation component, while variability within populations was 95.89%. It is suggested that the reason for the weak differentiation of local sea herring populations may be an intensive gene flow.
- 17 July 2008
- Published by Pleiades Publishing Ltd in Biology Bulletin
- Vol. 35 (4) , 368-373
Genetic diversity of the striped field mouse (Apodemus agrarius Pallas, 1771) in the Russian Far East as assessed by RAPD-PCR
Random amplified polymorphic DNA (RAPD) analysis based on polymerase chain reaction (PCR) with ten-nucleotide primers of arbitrary sequences (RAPD-PCR) was used to study the genetic characteristics of five samples of the striped field mouse (Apodemus agrarius Pallas, 1771) from the Russian Far East (Primorye, Khabarovsk krai, and Magadan oblast). Highly significant differentiation of the samples was demonstrated, the genetic diversity of each sample was estimated, and non-neutral loci were found. The genetic diversity was the highest in a population from the outskirts of Magadan and the lowest in populations from an island on the Amur River near Khabarovsk and from the village of Talon (Magadan oblast). These two last populations were found to be genetically close to each other. These results indicate that striped field mice have been repeatedly introduced to Magadan oblast. The Talon population is likely to have originated from the left bank of the Amur; the outskirts of Magadan are inhabited with a mixed population formed by mice from Primorye and other regions.
- 17 July 2008
- Published by Pleiades Publishing Ltd in Biology Bulletin
- Vol. 35 (4) , 368-373
Genetic diversity of the striped field mouse (Apodemus agrarius Pallas, 1771) in the Russian Far East as assessed by RAPD-PCR
Random amplified polymorphic DNA (RAPD) analysis based on polymerase chain reaction (PCR) with ten-nucleotide primers of arbitrary sequences (RAPD-PCR) was used to study the genetic characteristics of five samples of the striped field mouse (Apodemus agrarius Pallas, 1771) from the Russian Far East (Primorye, Khabarovsk krai, and Magadan oblast). Highly significant differentiation of the samples was demonstrated, the genetic diversity of each sample was estimated, and non-neutral loci were found. The genetic diversity was the highest in a population from the outskirts of Magadan and the lowest in populations from an island on the Amur River near Khabarovsk and from the village of Talon (Magadan oblast). These two last populations were found to be genetically close to each other. These results indicate that striped field mice have been repeatedly introduced to Magadan oblast. The Talon population is likely to have originated from the left bank of the Amur; the outskirts of Magadan are inhabited with a mixed population formed by mice from Primorye and other regions.